Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.62 |
| ▸ | MAOB | P27338 | 7/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30584498 | 1.00 | MAOA (0.62) | MAOAMAOBMAPTALDH1A1MEN1 | |
| Ammonia Solution, Strong SCHEMBL6557053 | 0.98 | MAOA (0.60) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL6856729 | 0.91 | SRC (0.56) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL6557043 | 0.88 | MAOA (0.51) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL2534036 | 0.87 | MAOA (0.62) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL11222905 | 0.87 | MAOB (0.59) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL6853633 | 0.87 | SRC (0.53) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL31599170 | 0.87 | SRC (0.53) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL6849018 | 0.87 | SRC (0.60) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL30631693 | 0.87 | SRC (0.60) | MAOAMAOBMAPTALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118439937-A | Synthetic method of 4-fluoro-3-phenoxybenzaldehyde serving as key intermediate of insect repellent | 康龙化成(绍兴)药业有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-116410070-A | Production process of p-fluoro-m-phenoxy benzaldehyde | 江苏优嘉植物保护有限公司 | 2023-07-11 | — | — | CN | claimed |
| WO-1999038833-A1 | PROCESS FOR THE HALOGENATION OF ALDEHYDES AND KETONES | BROMINE COMPOUNDS LTD. (IL) | 1999-08-05 | — | — | WO | claimed |
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMA INC (US) | 2026-03-05 | — | — | US | disclosed |
| CN-223875002-U | Byproduct collection and storage mechanism for preparing p-fluoro-m-phenoxy benzaldehyde | 湖南道仕医药科技有限公司 | 2026-02-06 | — | — | CN | disclosed |
| CN-223875002-U | Byproduct collection and storage mechanism for preparing p-fluoro-m-phenoxy benzaldehyde | 湖南道仕医药科技有限公司 | 2026-02-06 | — | — | CN | disclosed |
| EP-4273143-B1 | DERIVATIVE OF 2,5-DIKETOPIPERAZINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | DALIAN WZ PROBIOTICS AD HEALTH CO LTD (CN) | 2025-05-21 | — | — | EP | disclosed |
| EP-3936192-B1 | PYRROLOPYRAZOLE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2025-04-09 | — | — | EP | disclosed |
| US-12240855-B2 | Pyrrolopyrazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-03-04 | — | — | US | disclosed |
| CN-118439937-A | Synthetic method of 4-fluoro-3-phenoxybenzaldehyde serving as key intermediate of insect repellent | 康龙化成(绍兴)药业有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-20240140941-A1 | DERIVATIVE OF 2,5-DIKETOPIPERAZINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | DALIAN WZ PROBIOTICS AD HEALTH CO., LTD (CN) | 2024-05-02 | — | — | US | disclosed |
| US-4309555-A | Novel cyclopropane derivatives | CIBA-GEIGY CORPORATION (US) | 1982-01-05 | — | — | US | disclosed |
| EP-0041021-A2 | Cyclopropane carboxylic acid derivatives, their preparation, their use against parasites in plants and animals, their compositions and their intermediates | ROUSSEL-UCLAF (FR) | 1981-12-02 | — | — | EP | disclosed |
| US-4293504-A | Process for preparing optically active α-cyano-3-(4-halogenophenoxy)-benzyl 2-(4-chlorophenyl)isovalerate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-06 | — | — | US | disclosed |
| US-4279923-A | Combating pests with 3-(2,3-dichloro-3,3-difluoro-prop-1-en-1-yl)-2,2-dimethyl-cyclo-propanecarboxylic acid fluoro-benzyl esters | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-21 | — | — | US | disclosed |
| EP-0029543-A1 | Fluorinated benzylic esters of spirocarboxylic acids, process for their preparation and their use in pesticides | BAYER AG (DE) | 1981-06-03 | — | — | EP | disclosed |
| EP-0029515-A1 | Fluoro-substituted 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid benzyl esters, process for their preparation and their use in pesticides | BAYER AG (DE) | 1981-06-03 | — | — | EP | disclosed |
| EP-0026437-A1 | 3-(2,3-dichloro-3,3-difluoro-prop-1-en-1-yl)2,2 dimethyl cyclopropionic acid fluorobenzyl esters, process for their manufacture and their use in pesticides | BAYER AG (DE) | 1981-04-08 | — | — | EP | disclosed |
| EP-0025925-A1 | Process for the preparation of alpha-cyano-phenoxy benzylic esters | BAYER AG (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4242357-A | INSECTICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | C9, SSB, C1S | MAOA 3388/4885MAOB 2275/4885MAPT 1355/4885 |
| US-20240140941-A1 | DERIVATIVE OF 2,5-DIKETOPIPERAZINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | WEE1, WEE2, CYP51A1 | MAOA 3832/4885MAOB 3540/4885MAPT 173/4885 |
| US-12240855-B2 | Pyrrolopyrazole derivative | PTDSS1, PTDSS2, SMPD1 | MAOA 4824/4885MAOB 4731/4885MAPT 4781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.